Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 7/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carabrol SCHEMBL30932148 | 0.81 | PTGS2 (0.39) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29690860 | 0.64 | PTGS2 (0.40) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL13555308 | 0.64 | PTGS2 (0.48) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL8513390 | 0.64 | PTGS2 (0.48) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| Telekin SCHEMBL29780465 | 0.61 | NLRP3 (0.51) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| Tomentosin SCHEMBL10028477 | 0.61 | KDR (0.58) | NLRP3PTGS2NPC1MAPTXBP1 | |
| SCHEMBL31379748 | 0.60 | KDM1A (0.49) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL30366249 | 0.60 | NLRP3 (0.41) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29362695 | 0.59 | KMT2A (0.49) | NLRP3PTGS2CYP2D6CYP2C9CYP2C19 | |
| Secotanapartholide A SCHEMBL6365420 | 0.58 | KAT2A (0.35) | NLRP3PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260068884-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | JIANGSU FLAG CHEMICAL INDUSTRY CO., LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4581931-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | Jiangsu Flag Chemical Industry Co., Ltd. (CN) | 2025-07-09 | — | — | EP | claimed |
| CN-119112731-A | Inula helveticus extract and preparation method and application thereof | 南京中医药大学 | 2024-12-13 | — | — | CN | claimed |
| US-20260068884-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | JIANGSU FLAG CHEMICAL INDUSTRY CO., LTD. (CN) | 2026-03-12 | — | — | US | disclosed |
| EP-4581931-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | Jiangsu Flag Chemical Industry Co., Ltd. (CN) | 2025-07-09 | — | — | EP | disclosed |
| CN-119112731-A | Inula helveticus extract and preparation method and application thereof | 南京中医药大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-119112731-A | Inula helveticus extract and preparation method and application thereof | 南京中医药大学 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024046311-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | 江苏中旗科技股份有限公司 | 2024-03-07 | — | — | WO | disclosed |
| CN-117202791-A | Use of high quality protein concentrate as aquatic shellfish antimicrobial | 普莱瑞水产技术有限责任公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116134146-A | Microorganism-based process for obtaining improved quality protein concentrate | 普莱瑞水产技术有限责任公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-109068605-B | Parthenocarpic plants and methods of producing the same | 以色列国家农业和农村发展农业研究组织沃尔坎尼中心 | 2022-11-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068884-A1 | COMPOSITION USED FOR KILLING FUNGI AND METHOD FOR APPLYING COMPOSITION | CYP51A1, FBL, PTMA | NLRP3 2071/4885PTGS2 1435/4885CYP2D6 560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.